PLP1-Targeting Antisense Oligonucleotides Improve FOXG1 Syndrome Mice
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910846 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Daniel C S Tan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dementia Research Centre, Department of Biomedical Sciences, Faculty of Medicine Health and Human Sciences, Macquarie University, Sydney, NSW 2109, A…. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, Nerve Tissue Proteins, Oligonucleotides, Antisense. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, National Health and Medical Research Council, Australian FOXG1 foundation.
Abstract (Originalsprache)
FOXG1 syndrome is a rare neurodevelopmental disorder of the telencephalon, for which there is no cure. Underlying heterozygous pathogenic variants in the Forkhead Box G1 (FOXG1) gene with resulting impaired or loss of FOXG1 function lead to severe neurological impairments. Here, we report a patient with a de novo pathogenic single nucleotide deletion c.946del (p.Leu316Cysfs*10) of the FOXG1 gene that causes a premature protein truncation. To study this variant in vivo, we generated and characterized Foxg1 c946del mice that recapitulate hallmarks of the human disorder. Accordingly, heterozygous Foxg1 c946del mice display neurological symptoms with aberrant neuronal networks and increased seizure susceptibility. Gene expression profiling identified increased oligodendrocyte- and myelination-related gene clusters. Specifically, we showed that expression of the c946del mutant and of other pathogenic FOXG1 variants correlated with overexpression of proteolipid protein 1 (Plp1), a gene linked to white matter disorders. Postnatal administration of Plp1-targeting antisense oligonucleotides (ASOs) in Foxg1 c946del mice improved neurological deficits. Our data suggest Plp1 as a new target for therapeutic strategies mitigating disease phenotypes in FOXG1 syndrome patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dementia Research Centre, Department of Biomedical Sciences, Faculty of Medicine Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.
- Biological Resources Imaging Laboratory, University of New South Wales, Sydney, NSW 2052, Australia.
ORCID-Profile: Daniel C S Tan, Yazi D Ke, Lars M Ittner
Förderung
- Australian Research Council
- National Health and Medical Research Council
- Australian FOXG1 foundation
- National Health & Medical Research Council
- Macquarie University
Zitieren
APA
Tan, D. C. S., Jung, S., Deng, Y., Morey, N., Chan, G., Bongers, A., Ke, Y. D., Ittner, L. M., & Delerue, F. (2024). PLP1-Targeting Antisense Oligonucleotides Improve FOXG1 Syndrome Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910846
Vancouver
Tan DCS, Jung S, Deng Y, Morey N, Chan G, Bongers A, et al. PLP1-Targeting Antisense Oligonucleotides Improve FOXG1 Syndrome Mice. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910846
BibTeX
@article{Tan2024,
author = {Tan, Daniel C S and Jung, Seonghee and Deng, Yuanyuan and Morey, Nicolle and Chan, Gabriella and Bongers, Andre and Ke, Yazi D and Ittner, Lars M and Delerue, Fabien},
title = {PLP1-Targeting Antisense Oligonucleotides Improve FOXG1 Syndrome Mice},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910846}
}
EUVIMED